scholarly journals Spectrum of clinical applications of interlead ECG heterogeneity assessment: From myocardial ischemia detection to sudden cardiac death risk stratification

Author(s):  
Richard L. Verrier ◽  
Bruce D. Nearing ◽  
Andre D’Avila
2019 ◽  
Vol 23 (3) ◽  
pp. 1049-1057
Author(s):  
Alba Martin-Yebra ◽  
Pablo Laguna ◽  
Iwona Cygankiewicz ◽  
Antoni Bayes-de-Luna ◽  
Enrico G. Caiani ◽  
...  

2015 ◽  
Vol 68 (6) ◽  
pp. 544
Author(s):  
Marina Martínez-Moreno ◽  
Vicente Climent ◽  
Antonio García-Honrubia ◽  
Francisco Marín

EP Europace ◽  
2017 ◽  
Vol 19 (suppl_3) ◽  
pp. iii128-iii128
Author(s):  
C-K Antoniou ◽  
K. Gatzoulis ◽  
S. Georgopoulos ◽  
A. Anastasakis ◽  
A. Theopistou ◽  
...  

2015 ◽  
Vol 116 (12) ◽  
pp. 1907-1918 ◽  
Author(s):  
Marc W. Deyell ◽  
Andrew D. Krahn ◽  
Jeffrey J. Goldberger

Heart ◽  
2017 ◽  
Vol 103 (Suppl 1) ◽  
pp. A2.1-A2
Author(s):  
Brian P Halliday ◽  
Ankur Gulati ◽  
Aamir Ali ◽  
Kaushik Guha ◽  
Simon Newsome ◽  
...  

2018 ◽  
Vol 2018 (3) ◽  
Author(s):  
Paloma Jordà ◽  
Ana García-Álvarez

[first paragraph of article]Sudden cardiac death (SCD) is a devastating and often unpredictable complication of hypertrophic cardiomyopathy (HCM) that may occur as the initial disease presentation, frequently in asymptomatic or mildly symptomatic young people. Until 2000, only small series of patients examining predictors of SCD had been published, with a selection bias towards severe disease. Subsequently, larger series that are more representative of the HCM spectrum have shown that the annual SCD rate is less than 1%, and that there are subgroups of patients with a clearly higher risk.


Sign in / Sign up

Export Citation Format

Share Document